Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Leukemia 6Leukemia, Myeloid, Acute 5Myelodysplastic Syndromes 4Lymphoma 4Lymphoma, Non-Hodgkin 3Graft vs Host Disease 3Congenital Abnormalities 3Anemia, Refractory, with Excess of Blasts 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Recurrence 1Neuroblastoma 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hematologic Neoplasms 1Genetic Diseases, Inborn 1Burkitt Lymphoma 1Blast Crisis 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 3fludarabine phosphate 2Whole-Body Irradiation 2Tacrolimus 2Methotrexate 2Busulfan 2Alemtuzumab 2AP 1903 reagent 2visilizumab 1thymoglobulin 1fludarabine 1Transplantation 1Teriparatide 1Saline Solution 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Parathyroid Hormone 1Melphalan 1Heparin 1Fluorescent Antibody Technique 1Ficusin 1Etoposide 1Cytarabine 1Cord Blood Stem Cell Transplantation 1Clofarabine 1Carmustine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Anemia, Aplastic × Transplantation × Clear all
NCT00212407 2018-11-02

New York Blood Center National Cord Blood Program

New York Blood Center

Phase EARLY_PHASE1 Terminated
4,476 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡